Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Protease resistance of food proteins: a mixed picture for predicting allergenicity but a useful tool for assessing exposure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The Polygenic and Monogenic Basis of Blood Traits and Diseases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • M A Calderon
  • P Demoly
  • T Casale
  • C A Akdis
  • C Bachert
  • M Bewick
  • B M Bilò
  • B Bohle
  • S Bonini
  • A Bush
  • D P Caimmi
  • G W Canonica
  • V Cardona
  • A M Chiriac
  • L Cox
  • A Custovic
  • F De Blay
  • P Devillier
  • A Didier
  • G Di Lorenzo
  • G Du Toit
  • S R Durham
  • P Eng
  • A Fiocchi
  • A T Fox
  • R Gerth van Wijk
  • R M Gomez
  • T Haathela
  • S Halken
  • P W Hellings
  • L Jacobsen
  • J Just
  • L K Tanno
  • J Kleine-Tebbe
  • L Klimek
  • E F Knol
  • P Kuna
  • D E Larenas-Linnemann
  • A Linneberg
  • M Matricardi
  • H J Malling
  • R Moesges
  • J Mullol
  • A Muraro
  • N Papadopoulos
  • G Passalacqua
  • E Pastorello
  • O Pfaar
  • D Price
  • P Rodriguez Del Rio
  • R Ruëff
  • B Samolinski
  • G K Scadding
  • G Senti
  • M H Shamji
  • A Sheikh
  • J C Sisul
  • D Sole
  • G J Sturm
  • A Tabar
  • R Van Ree
  • M T Ventura
  • C Vidal
  • E M Varga
  • M Worm
  • T Zuberbier
  • J Bousquet
Vis graf over relationer

Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.

OriginalsprogEngelsk
TidsskriftClinical and translational allergy
Vol/bind6
Sider (fra-til)41
DOI
StatusUdgivet - 2016

ID: 49817537